Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Vitamin d and multiple sclerosis.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
[Neuromyelitis optica spectrum disorder: a case report].
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Biologic therapies: lessons from multiple sclerosis.
Daughters of mothers with multiple sclerosis: their experiences of play.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

Pages